Atlas Trials

Study of ADXS-504 Immunotherapy for Recurrent Prostate Cancer

Clinical trial NCT05077098 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05077098
Sponsor
Mark Stein
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Recurrent Prostate Cancer
Start date
2021-08-12
Primary completion
2026-07-01
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.